Nephros Average Inventory from 2010 to 2026

NEPH Stock  USD 3.91  0.09  2.25%   
Nephros' Average Inventory is decreasing with very volatile movements from year to year. Average Inventory is predicted to flatten to about 464.6 K. Average Inventory is the average amount of inventory Nephros holds over a certain period, which is used to calculate inventory turnover and efficiency in managing stock levels. View All Fundamentals
 
Average Inventory  
First Reported
2010-12-31
Previous Quarter
660.6 K
Current Value
464.6 K
Quarterly Volatility
95.8 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Nephros financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nephros' main balance sheet or income statement drivers, such as Depreciation And Amortization of 117.1 K, Interest Expense of 855 or Total Revenue of 17.1 M, as well as many indicators such as Price To Sales Ratio of 1.19, Dividend Yield of 0.0144 or PTB Ratio of 1.54. Nephros financial statements analysis is a perfect complement when working with Nephros Valuation or Volatility modules.
  
Build AI portfolio with Nephros Stock
Check out the analysis of Nephros Correlation against competitors.
For more detail on how to invest in Nephros Stock please use our How to Invest in Nephros guide.
The Average Inventory trend for Nephros offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Nephros is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Nephros' Average Inventory Growth Pattern

Below is the plot of the Average Inventory of Nephros over the last few years. It is the average amount of inventory a company holds over a certain period, which is used to calculate inventory turnover and efficiency in managing stock levels. Nephros' Average Inventory historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nephros' overall financial position and show how it may be relating to other accounts over time.
Average Inventory10 Years Trend
Very volatile
   Average Inventory   
       Timeline  

Nephros Average Inventory Regression Statistics

Arithmetic Mean695,773
Geometric Mean687,855
Coefficient Of Variation13.77
Mean Deviation62,878
Median733,950
Standard Deviation95,836
Sample Variance9.2B
Range306.3K
R-Value(0.03)
Mean Square Error9.8B
R-Squared0.0008
Significance0.91
Slope(534.01)
Total Sum of Squares147B

Nephros Average Inventory History

2026464.6 K
2025660.6 K
2011734 K
2010427.7 K

About Nephros Financial Statements

Investors use fundamental indicators, such as Nephros' Average Inventory, to determine how well the company is positioned to perform in the future. Although Nephros' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Average Inventory660.6 K464.6 K

Currently Active Assets on Macroaxis

When determining whether Nephros offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nephros' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nephros Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nephros Stock:
Check out the analysis of Nephros Correlation against competitors.
For more detail on how to invest in Nephros Stock please use our How to Invest in Nephros guide.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is there potential for Household Appliances market expansion? Will Nephros introduce new products? Factors like these will boost the valuation of Nephros. Anticipated expansion of Nephros directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Nephros listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.729
Earnings Share
0.14
Revenue Per Share
1.693
Quarterly Revenue Growth
0.354
Return On Assets
0.0764
The market value of Nephros is measured differently than its book value, which is the value of Nephros that is recorded on the company's balance sheet. Investors also form their own opinion of Nephros' value that differs from its market value or its book value, called intrinsic value, which is Nephros' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Nephros' market value can be influenced by many factors that don't directly affect Nephros' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Nephros' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Nephros should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Nephros' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.